Kijimea IBS

Kijimea IBS is a dietary supplement developed by Synformulas GmbH, a German company specializing in probiotic products aimed at supporting gut health. The product is manufactured in multiple countries, including Germany, Italy, and the United States, under stringent quality standards. Kijimea IBS contains the unique probiotic strain Bifidobacterium bifidum MIMBb75, which has been clinically researched for its efficacy in reducing symptoms associated with irritable bowel syndrome (IBS), such as abdominal pain, bloating, and digestive disorders. The product is free from preservatives, sweeteners, flavoring agents, lactose, gluten, and gelatin, making it suitable for a wide range of consumers. Synformulas GmbH continues to lead in the development of innovative probiotic solutions for digestive health.